DK13990A - Superaktive humane insulinanaloge - Google Patents

Superaktive humane insulinanaloge Download PDF

Info

Publication number
DK13990A
DK13990A DK013990A DK13990A DK13990A DK 13990 A DK13990 A DK 13990A DK 013990 A DK013990 A DK 013990A DK 13990 A DK13990 A DK 13990A DK 13990 A DK13990 A DK 13990A
Authority
DK
Denmark
Prior art keywords
human insulin
insulin analogue
superactive
superactive human
analogue
Prior art date
Application number
DK013990A
Other languages
English (en)
Other versions
DK13990D0 (da
Inventor
Panyaotis G Katsoyannis
Gerald P Schwartz
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Publication of DK13990A publication Critical patent/DK13990A/da
Publication of DK13990D0 publication Critical patent/DK13990D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK013990A 1987-07-17 1990-01-17 Superaktive humane insulinanaloge DK13990D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/074,558 US4992418A (en) 1987-07-17 1987-07-17 Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
PCT/US1988/002289 WO1989000580A1 (en) 1987-07-17 1988-07-07 Superactive human insulin analogues

Publications (2)

Publication Number Publication Date
DK13990A true DK13990A (da) 1990-01-17
DK13990D0 DK13990D0 (da) 1990-01-17

Family

ID=22120214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK013990A DK13990D0 (da) 1987-07-17 1990-01-17 Superaktive humane insulinanaloge

Country Status (10)

Country Link
US (1) US4992418A (da)
EP (1) EP0382732B1 (da)
JP (1) JP2729498B2 (da)
KR (1) KR970009353B1 (da)
AU (1) AU616131B2 (da)
DE (1) DE3887338T2 (da)
DK (1) DK13990D0 (da)
FI (1) FI98731C (da)
HU (1) HU205145B (da)
WO (1) WO1989000580A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
DE69221725T2 (de) * 1991-05-24 1997-12-18 Amylin Pharmaceuticals, Inc., San Diego, Calif. Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
IL102240A0 (en) * 1991-06-21 1993-01-14 Lilly Co Eli Insulin analogs
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
WO2002101074A2 (en) * 2001-06-08 2002-12-19 Boehringer Ingelheim Pharmaceuticals, Inc. Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
ES2554773T3 (es) 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
US8354435B2 (en) 2008-09-08 2013-01-15 The Board Of Trustees Of The Leland Stanford Junior University Modulators of aldehyde dehydrogenase activity and methods of use thereof
CN102202669A (zh) 2008-10-28 2011-09-28 利兰·斯坦福青年大学托管委员会 醛脱氢酶调节剂及其使用方法
WO2012149106A1 (en) 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
US9908925B2 (en) 2011-10-27 2018-03-06 Case Western Reserve University Ultra-concentrated rapid-acting insulin analogue formulations
JP6410790B2 (ja) 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3420810A (en) * 1966-10-25 1969-01-07 Atomic Energy Commission Process for joining the a and b chains of insulin
DE2252157C3 (de) * 1972-10-25 1976-03-18 Hoechst Ag Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten
DE2253327A1 (de) * 1972-10-31 1974-05-09 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DD153829A1 (de) * 1979-08-09 1982-02-03 Guenter Losse Verfahren zur herstellung neuartiger hybridinsuline mit insulinaehnlicher wirkung
US4421685A (en) * 1980-03-27 1983-12-20 Eli Lilly And Company Process for producing an insulin
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
US4652548A (en) * 1981-08-27 1987-03-24 Eli Lilly And Company Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
DOP1982004086A (es) * 1981-08-27 1988-03-22 Lilly Co Eli Formula farmaceutica que comprende insulina humana y proinsulina humana
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.
US4581165A (en) * 1984-06-14 1986-04-08 Eli Lilly And Company Anti-diabetic compounds
US4569792A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US4569791A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
EP0382732B1 (en) 1994-01-19
HUT54178A (en) 1991-01-28
AU2126988A (en) 1989-02-13
AU616131B2 (en) 1991-10-17
JP2729498B2 (ja) 1998-03-18
WO1989000580A1 (en) 1989-01-26
EP0382732A1 (en) 1990-08-22
KR970009353B1 (ko) 1997-06-10
FI98731B (fi) 1997-04-30
DE3887338D1 (de) 1994-03-03
HU205145B (en) 1992-03-30
JPH02504274A (ja) 1990-12-06
DK13990D0 (da) 1990-01-17
FI900249A0 (fi) 1990-01-16
KR920700227A (ko) 1992-02-19
DE3887338T2 (de) 1994-05-05
FI98731C (fi) 1997-08-11
US4992418A (en) 1991-02-12

Similar Documents

Publication Publication Date Title
BG90716A (bg) Спринцовка
PT88672A (pt) Syringe
DE10075034I1 (de) Insulinderivate
DK13990D0 (da) Superaktive humane insulinanaloge
BR8806571A (pt) Indazois substituidos inseticidas
DK539988D0 (da) Ballepresser
DK539888D0 (da) Ballepresser
DK54589A (da) Humane kolonistmulerende faktorer
DK444288A (da) Humant reg - protein
DK13889D0 (da) Insecticid
DK327488A (da) Kanyle
MX14038A (es) Composicion insecticida
DK239588D0 (da) Kornformigt adsorptionsmiddel
KR890701560A (ko) N-시아노메틸-2-피리디논 살충제
DK540088A (da) Ballepresser
NO891156L (no) Superaktive humane insulinanaloger.
ATE100468T1 (de) Superaktive menschliche insulin-analoge.
DK539788A (da) Ballepresser
KR890012334U (ko) 쥐 덫
KR890010164U (ko) 장식용 인조 소나무
NO884613D0 (no) Human interleukin-3- og muteiner derav.
DK721588D0 (da) Humaninsulinanaloger
DK119391D0 (da) Humaninsulinanaloger
BR8705552A (pt) Aparelho exterminador de insetos
KR880017148U (ko) 전자훈증기

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment